<img alt="53745962_1609894054298226_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/53745962_1609894054298226_r.jpeg" width="100%" />
<div><br />
</div>
<div>Dear donors 
</div>
<div><br />
</div>
<div>Thank you again for your kind donations to the Matthew Fisher Sarcoma Research Fund. It’s almost been three years since his death and the establishment of his research fund, Matt’s final wish to support critical research to change the current trajectory for patients living with a sarcoma diagnosis. 
</div>
<div><br />
</div>
<div>We are pleased to let you know that the first round results of the IL 23 trial can now be widely shared. 
</div>
<div><br />
</div>
<div>The trial lead, Professor David Thomas will be presenting virtually to the Matthew Fisher Sarcoma Research Fund donors on Tuesday 14 November at 12.30 pm (Canberra time). The online presentation will be followed by a short Q&amp;A session.
</div>
<div><br />
</div>
<div>The link to the live presentation will be provided on this site the day before the event. 
</div>
<div><br />
</div>
<div>For those based in Canberra, IP Australia Canberra office will be hosting the event at their Amenities Room, near the Security Desk in the main foyer. Cooper Rice-Brading Foundation will be providing a light lunch. If you would like to attend in person, please RSVP to [email redacted].au for catering purposes. 
</div>
<div><br />
</div>
<div>For those who are not able to join the presentation live, a recording will be available at a later date. 
</div>
<div><br />
</div>
<div><strong>About Professor David Thomas</strong>
</div>
<div>Professor David Thomas is CEO of Omico since 2018: the Australian Genomic Cancer Medicine Centre and inaugural Director of the Centre for Molecular Oncology at UNSW. He has a background in medicine and cancer research. He undertook his medical training at the University of Melbourne (1982-1988), and completed his PhD at the University of Melbourne in 1997. He was the founding Chair and board member of the Australasian Sarcoma Study Group (2007-18). He heads the Garvan Institute of Medical Research’s Genomic Cancer Medicine Laboratory. 
</div>
<div><br />
</div>
<div><strong>The Cooper Rice-Brading Foundation (CRBF)</strong>
</div>
<div>Is dedicated to the fight against sarcoma, a cancer of the connective tissue and bone, affecting all ages, but disproportionately affecting children, adolescents and young adults. For more information, please visit crbf.org.au
</div>
<div><br />
</div>
<div>-------------------------------------------------------------------------------------------
</div>
<div><br />
</div>
<div>Matt was diagnosed with a rare aggressive cancer rhabdomyosarcoma in February 2020, and unfortunately this has proved to be terminal. Matt’s down-to-earth and caring nature for his family (wife Naomi, two daughters Vivi and Sylvie), friends and work colleagues is well known. Now we’d like to support Matt’s final wish for increased sarcoma research.
</div>
<div><br />
</div>
<div>Throughout his treatment in 2020, Matt continued to be your typical chemical patent examiner and would research the patents on his chemotherapy drugs and relay what he found to his oncologist, who believed one was an invention stolen from Australia.
</div>
<div><br />
</div>
<div>Given his scientific research background, it's no surprise that his final wish was to support critical research required to change the current trajectory for patients living with a sarcoma diagnosis. 
</div>
<div><br />
</div>
<div>All raised funds will be passed to The Cooper Rice-Brading Foundation, which is currently seeking funds for the a world first IL23 sarcoma clinical study in conjunction with the Garvan Institute of Medical Research. This fund is being named in Matt’s honour.
</div>
<div><br />
</div>
<div>For more information on the The Matthew Fisher Sarcoma Research Fund, please visit <a href="https://www.crbf.org.au/matthew-fisher-sarcoma-research-fund/" target="_blank" rel="noreferrer noopener"><a href="https://www.crbf.org.au/matthew-fisher-sarcoma-research-fund/" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.crbf.org.au/matthew-fisher-sarcoma-research-fund/</a></a>
</div>
<div><br />
</div>

Judy Dreverman

Anonymous

Duncan Fisher

Susan Menadue-Chun

Paul Gardner

Alyssa Kirk

Kate Williams

Jonathan Page

Mel O’Byrne 

Melissa Savage

Simon & Shannon Holding

Matthew Fisher Sarcoma Research Fund

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

Eligible for Profile Share Badge

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

Support Comments Allowlist

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

checkout headers audience

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

isEligibleForProfileBadge

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Enter your donation forMatthew Fisher Sarcoma Research Fund